Corresponding Article
Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin Ototoxicity
- Panizza, Benedict J. MBBS, MBA, FRACS, FACS2,
- O'Leary, Stephen John PhD, MBBS, BMedSci, FRACS3
- Hart, Christopher David MBBS, BA, BSc, FRACP4
- Diwakarla, Chandra Sai MBBS, BSc (Hons), FRACP5,
- Barnett, Catherine MBBS, MPhil, MSc, BSc, FRACS1
- Lapuerta, Pablo MD6,,
- Lee, John PhD7,
- Raines, Shane MS7,
- Quigley, Tera AuD7,
- Wolff, Heather M. BA7
- Keilty, John MS7,
- Ladwa, Rahul MBCHB, MPhil, BSc, FRACP2,
- Porceddu, Sandro V. MD, MBBS, BSc, FRANZCR8,
- McGrath, Margaret FRACP1,
- Seetharamu, Nagashree MD, MBBS9,
- Fua, Tsien MBBS, FRANZCR2
- Rischin, Danny MD, MBBS8,
Journal of Clinical Oncology 43(19):p 2155-2163, July 1, 2025. | DOI: 10.1200/JCO.24.00905